Familial colorectal cancer type X syndrome: Two distinct molecular entities?

Familial Cancer

Volumn 10, Issue 4, 2011, Pages 623-631

  Francisco, Inês ^a   Albuquerque, Cristina ^a   Lage, Pedro ^a   Belo, Hélio ^a   Vitoriano, Inês ^a   Filipe, Bruno ^a   Claro, Isabel ^a   Ferreira, Sara ^a   Rodrigues, Paula ^a   Chaves, Paula ^a   Leitão, Carlos Nobre ^a,b   Pereira, António Dias ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b Clinica Feminologia Holistica   (Portugal)

Author keywords

Colorectal cancer; Familial colorectal cancer type X; Lynch syndrome

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53; SMAD4 PROTEIN;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GENETICS; CLINICAL FEATURE; DISEASE SEVERITY; GENE IDENTIFICATION; HEREDITARY COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; ONCOGENE K RAS; PRIORITY JOURNAL; RECTUM CANCER; SOMATIC MUTATION; SYNDROME X; TUMOR SUPPRESSOR GENE;

EID: 84855696555     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9473-7     Document Type: Article

References (35)

1. Vasen H, Watson P, Mecklin J et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456 (Pubitemid 29258894)
2. Jass JR (2006) Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 12(31): 4943-4950 (Pubitemid 44323261)
3. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10):919-932 (Pubitemid 36298000)
4. Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 293(16):1979-1985 (Pubitemid 40570891)
5. Boland CR (2005) Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 4(3):211-218 (Pubitemid 41242189)
6. Mueller-Koch Y, Vogelsang H, Kopp R et al (2005) Hereditary non-polyposis colorectal cancer: Clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 54(12): 1733-1740 (Pubitemid 41697672)
7. Dove-Edwin I, de Jong AE, Adams J et al (2006) Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without lynch syndrome. Gastroenterology 130(7):1995-2000 (Pubitemid 43816950)
8. Vasen HFA, Abdirahman M, Brohet R et al (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with lynch syndrome. Gastroenterology 138(7):2300-2306
9. Ferreira S, Lage P, Sousa R et al (2009) Familial colorectal cancer type X: Clinical, pathological and molecular characterization. Acta Med Port 22(3):207-214
10. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
11. Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66(3):589-600
12. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949-954 (Pubitemid 34716871)
13. Gylling A, Ridanpää M, Vierimaa O et al (2009) Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer 124(10):2333-2340
14. Goel A, Arnold CN, Niedzwiecki D et al (2003) Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63(7):1608-1614 (Pubitemid 36373651)
15. Bodmer WF (2006) Cancer genetics: Colorectal cancer as a model. J Hum Genet 51(5):391-396 (Pubitemid 43863773)
16. Imai Y, Oda H, Tsurutani N et al (1997) Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas. Cancer Sci 88(9):846-854 (Pubitemid 27475086)
17. Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68(1):118-127 (Pubitemid 32048366)
18. Llor X, Pons E, Xicola RM et al (2005) Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11(20): 7304-7310 (Pubitemid 41507688)
19. Lindor N (2009) Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders. Best Pract Res Clin Gastroenterol 23(1):75-87
20. Lindor NM (2009) Familial colorectal cancer type X: The other half of hereditary nonpolyposis colon cancer syndrome. Surg Oncol Clin N Am 18(4):637-645
21. Jass JR, Cottier DS, Jeevaratnam P et al (1995) Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 346(8984):1200-1201
22. Valle L, Perea J, Carbonell P et al (2007) Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 25(7):781-786 (Pubitemid 350002877)
23. Abdel-Rahman WM, Ollikainen M, Kariola R et al (2005) Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 24(9): 1542-1551 (Pubitemid 40396084)
24. Sanchez-de-Abajo A, de la Hoya M, van Puijenbroek M et al (2007) Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Clin Cancer Res 13(19):5729-5735 (Pubitemid 47583897)
25. Albuquerque C, Baltazar C, Filipe Bet al (2010) Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosom Cancer 49(8):746-759
26. Nagasaka T, Goel A, Notohara K et al (2008) Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer 122(11):2429-2436 (Pubitemid 351590474)
27. Goel A, Xicola RM, Nguyen T-P et al (2010) Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology 138(5):1854-1862
28. Cetta F, Montalto G, Gori M et al (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposisassociated thyroid carcinoma: Results from a european cooperative study. J Clin Endocrinol Metab 85(1):286-292 (Pubitemid 32268827)
29. Hahnloser D, Petersen GM, Rabe K et al (2003) The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol Biomarkers Prev 12(10):1023-1028 (Pubitemid 37310258)
30. Popat S, Stone J, Coleman G et al (2000) Prevalence of the APC E1317Q variant in colorectal cancer patients. Cancer Lett 149(1-2):203-206 (Pubitemid 30100577)
31. Frayling IM, Beck NE, Ilyas M et al (1998) The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA 95(18):10722-10727 (Pubitemid 28413135)
32. Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10(7):721-733 (Pubitemid 32331581)
33. Lamlum H, Al Tassan N, Jaeger E et al (2000) Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 9(15):2215-2221
34. Scott RJ, Crooks R, Rose L et al (2004) Germline missense changes in the APC gene and their relationship to disease. Hered Cancer Clin Pract 2(2):81-91
35. Dallosso AR, Jones S, Azzopardi D et al (2009) The APC variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations. Hum Mutat 30(10):1412-1418